The Promise and Perils of Diversity Action Plans for Clinical Trials
Varma T, Bierer B, Hantel A. The Promise and Perils of Diversity Action Plans for Clinical Trials. JAMA 2024, 332: 1787-1788. PMID: 39302826, PMCID: PMC11938119, DOI: 10.1001/jama.2024.18225.Peer-Reviewed Original ResearchClinical trialsDiversity action plansUS Food and Drug Administration authorityTrialsFood and Drug Administration authority
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply